Jose Luis Rodriguez-Bada
Overview
Explore the profile of Jose Luis Rodriguez-Bada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aliaga-Gaspar P, Brichette-Mieg I, Fernandez-Arjona M, Rodriguez-Bada J, Lopez-Moreno Y, Serrano-Castro P, et al.
Biomed Pharmacother
. 2024 Nov;
181:117678.
PMID: 39577364
Methods: An in-silico study was conducted to compare the structure of recombinant human soluble IFNAR2 (r-sIFNAR2) with its native form. The antiviral activity of r-sIFNAR2, produced in BL21-bacteria and CHO...
2.
Ciano-Petersen N, Aliaga-Gaspar P, Hurtado-Guerrero I, Reyes V, Rodriguez-Bada J, Rodriguez-Traver E, et al.
Front Immunol
. 2023 Sep;
14:1242508.
PMID: 37675113
Introduction: Natalizumab is a biologic drug for relapsing-remitting multiple sclerosis that may induce the generation of anti-drug antibodies in some patients. Anti-natalizumab antibodies (ANA) increase the risk of adverse events...
3.
Aliaga-Gaspar P, Hurtado-Guerrero I, Ciano-Petersen N, Urbaneja P, Brichette-Mieg I, Reyes V, et al.
Front Immunol
. 2022 Jan;
12:778204.
PMID: 34975865
Purpose: Interferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has...
4.
Hurtado-Guerrero I, Pinto-Medel M, Urbaneja P, Rodriguez-Bada J, Ortega-Pinazo J, Serrano P, et al.
Sci Rep
. 2017 Nov;
7(1):16585.
PMID: 29185487
Interferon beta (IFNβ) therapy has immunogenic properties and induces the development of neutralizing antibodies (NAbs). From the extensive literature focused in the development of NAbs in multiple sclerosis (MS) patients,...
5.
Hurtado-Guerrero I, Pinto-Medel M, Urbaneja P, Rodriguez-Bada J, Leon A, Guerrero M, et al.
PLoS One
. 2017 Jan;
12(1):e0170031.
PMID: 28103257
Interferon beta (IFNß) is a common treatment used for multiple sclerosis (MS) which acts through the activation of the JAK-STAT pathway. However, this therapy is not always effective and currently...
6.
Rondon C, Blanca-Lopez N, Aranda A, Herrera R, Rodriguez-Bada J, Canto G, et al.
J Allergy Clin Immunol
. 2011 Feb;
127(4):1069-71.
PMID: 21277626
No abstract available.
7.
Robles S, Torres M, Mayorga C, Rodriguez-Bada J, Fernandez T, Blanca M, et al.
Ann Allergy Asthma Immunol
. 2007 Jul;
98(6):600-2.
PMID: 17601280
No abstract available.